Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

CMED 311 > Trans 053 NMJ Disorders > Flashcards

Trans 053 NMJ Disorders Flashcards

1
Q

Most common NMJ Disease?

A

MG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

When we say NMJ, we are talking of receptors and neurotransmitters, specifically ______

A

Ach

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

This substance block Ach release?

A

Botulinum Toxin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

A drug that blocks Ach receptors? (poison darts)

A

Curare

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What blocks acetylcholinesterase?

A

Organophosphates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

3 mechanisms that causes NMJ problems?

A
  1. Decrease Ach release
  2. Decrease Ach effects on muscle cells
  3. Decreased acetylcholineesterase activity results in acetylcholine having a stronger effect on mm cell.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

NMJ problems can be post or presynaptic, T or F?

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Pattern of weakness in NMJ? proximal or distal?

A

Both

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

is extraocular and facial mm involved in weakness in NMJ?

A

Yes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

NMJ is [variable/constant] within the day?

A

Variable:

Nagkakaroon kasi ng fatigue, so pag active na active, you need more and more of the Ach, so the patient will have weakness. So patients with NMJ disorders, esp. with myasthenia gravis, pag gising sa umaga, malakas pero by midday, mahina na sila.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Are sensory and tendon reflexes affected in NMJ disorders?

A

No

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Fluctuating weakness is predominantly in proximal/distal muscles and associated with fatigability.

A

proximal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Ocular and bulbar muscles are frequently [more severely/not much affected]?

A

more severely

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Generalized fatigue without true weakness is not atypical. T or F?

A

F. TYPICAL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Symptoms of sensory loss, paresthesia, or neuropathic pain are absent. T or F?

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Autonomic symptoms of dry mouth, blurry vision, impotence, constipation, and difficulty with urination may be noted in

A

LEMS and botulism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Weakness with predilection for proximal limb, ocular, and bulbar muscles is not typical. T or F?

A

F. Typical

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Extraocular and bulbar weakness are early and prominent in MG and botulism but less prominent in LEMS. If ocular weakness is an initial symptom, LEMS is unlikely. T or F?

A

T. If ocular weakness is an initial symptom, LEMS is unlikely.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Pupillary responses are usually reduced in

A

Botulism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Pupils are not affected in MG. T or F?

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Reflexes are characteristically present/absent in presynaptic NMJDs but preserved/absent in postsynaptic NMJDs.

A

absent

preserved

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Facilitation of reflexes with brief exercise is pathognomonic of

A

LEMS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

NMJ DISORDERS can be subdivided into 3: what are those?

A

Toxin induced
Immune Mediated
Genetic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

For toxin induced NMJ disorder what are the examplse?

A

Botulism
snake venoms
organophosphates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

For Immune Mediated NMJ disorder, what are the example?

A

MG and LEMS

26
Q

For genetic NMJ problem what is the example?

A

Congenital Myasthenic syndrome

27
Q

in MG: Autoimmunity is directed toward the Ach receptor on the PRE/POST synaptic membrane?

A

postsynaptic membrane

28
Q

In LEMS: Autoimmunity is directed toward voltage gated calcium channels at the PRE/POST synaptic nerve terminal.

A

PRE

29
Q

mechanism of botulism

A

Botulinum toxin blocks neurotransmitter release at peripheral cholinergic nerve terminals (including skeletal muscle and autonomic nervous system).

30
Q

CMS: There are [numerous/rare] CMSs with various mutations affecting the function of either presynaptic, synaptic, and postsynaptic NMJ transmission.

A

numerous

31
Q

Serologic testing for MG:

A

Ach receptor antibodies (80%); muscle specific tyrosine kinase (MuSK) antibodies (10%); striational antibodies; antibody negative (5%- 10%).

32
Q

serologic testing for LEMS?

A

P/Q type voltage gated calcium channel antibodies are present in atleast 85% of LEMS.

33
Q

serologic testing for botulism?

A

Antibody testing is available to identify exposure to common subtypes.

34
Q

Aside from serologic tests what other tests can we do for NMJ d/o?

A

1.Toxin and culture analysis of feces, serum, wound, and food may be considered depending on suspected route of exposure in cases of botulism. 2.Genetic tests is available for some CMS disorders

35
Q

Typical result of Sensory nerve conduction studies in NMJDs

A

are typically normal in NMJDs and help exclude mimicking or coexistent conditions.

36
Q

Some patients with LEMS may have these findings in Nerve conductuion testinfs

A

Some patients with LEMS may have a concomitant paraneoplastic sensory or sensorimotor neuropathy or chemotherapy related peripheral neuropathy.

37
Q

Motor nerve conduction studies result p[ost synaptic NMJDs

A

are usually normal in postsynaptic NMJDs, but in severe cases, compound muscle action potential (CMAP) amplitudes may be slightly reduced while distal latencies and conduction velocities are normal.

38
Q

is a specialized motor nerve conduction study used to assess NMJDs.

 Ask the patient to raise their arms 20x up down up down, and try to see if the patient will have fatigue and compare it to a normal person.

A

RNS

Repetitive nerve stimulation

39
Q

What’s the disease?

Reflex: normal or reduced
CMAP: normal
3 Hz Stimulation: Decrement
50 Hz Stimulation: Decrement
Autonomic symptoms: Absent
A

MG

40
Q

What’s the disease?

Reflex: Absent
CMAP:Reduced
3 Hz Stimulation:Decrement 
50 Hz Stimulation: Increment
Autonomic symptoms: Dry mouth , constipation, male impotence
A

LEMS

41
Q

What’s the disease?

Reflex: Hyperactive or normal
CMAP: Normal amplitude; repetitive response to single stimulation, multiple spontaneous motor unit discharges
3 Hz Stimulation: Normal or decrement
50 Hz Stimulation: not performed
Autonomic symptoms: increased sweating or constipation

A

Neuromyotonia

42
Q

What’s the disease?

Reflex: Usually normal
CMAP: Normal in ACHR deficiency
3 Hz Stimulation: Normal/decrement
50 Hz Stimulation: not performed
Autonomic symptoms: Absent
A

Congenital myasthenic syndromes

43
Q

Pathophy of NMJ: Immunoglobulin G (IgG) directed attack on the NMJ, aimed specifically at the what receptor

A

nicotinic ach receptos

44
Q

Damage to the Ach receptor and postsynaptic membrane involves several steps:

A
  • First, binding of the antibody to the receptor can directly block the binding of Ach.
  • Second, there is a complement-directed attack, with destruction of the Ach receptor and post junctional folds.
  • Third, antibody binding can result in an increase in the normal removal of Ach receptors from the postsynaptic membrane.

> Resulting in a smaller endplate potential and a reduced safety factor of NMJ transmission.

45
Q

ocular findings in MG?

A
  • Unilateral painless ptosis without ophthalmoplegia will most often prove to be due to myasthenia.
  • Normal pupillary responses to light and on accommodation in the face of weakness of extraocular muscles and orbicularis oculi are virtually diagnostic of myasthenia gravis.
  • Attempts to overcome the ptosis may impart a staring expression
  • Bright sunlight is said to aggravate the ocular signs and cold to improve them.
46
Q

Ice test

A

put the ice on a piece of cloth, and put it on the patient for about 5 min, and ask the patient to open the eyes. If wider than the previous, then most likely it is myasthenia gravis

47
Q

classification/ distribution of weakness in MG

Class 1
Class 2 (2A and 2B)
Class 3 (3A and 3B)
Class 4 (4A and 4B)
Class 5
A 
1- ocular
2- mild generalized
2A-limb axial
2B oropharyngeal/respiratory muscles
3 - moderate generalized
3A - limb axial
3B - oropharyngeal/respiratory
4 - severe generalized
4A - limb axial
4B oro/respi
5 _intubation
48
Q
  • Infants born of myasthenic mothers
  • Self limited
  • Transplacental transfer of AchR
  • Antibodies

what type of pediatric MG?

A

Neonatal

49
Q

What type of pediatric MG?

  • Nonmyasthenic mother
  • Tends to be permanent
  • Onset anytime from birth to puberty
A

Juvenile

50
Q

drugs that may induce MG?

A

• Drugs may worsen syndromes

  • Polymixin and aminoglycoside antibiotics
  • Antiarrhythmic agents (procainamide, quinidine)
  • b-adrenergic blockers (propranolol, timolol)
  • Phenothiazines, lithium
  • Succinylcholine, curare, and related drugs
  • Trimethaphan
  • Methoxyflurane
  • Magnesium given parentally or in cathartics
51
Q

Result of Anti-Achr radioimmunoassay?

A

85% positive in generalized MG; 50% in ocular MG

52
Q

40% of AChR antibody-negative patients with generalized MG have anti-MuSK antibodies. T or F?

A

T

53
Q
  • Repetitive nerve stimulation: decrement of >10% at 3 Hz: highly probable
  • Single-fiber electromyography: blocking and jitter, with normal fiber density; confirmatory, but not specific • Edrophonium chloride (Tensilon) 2 mg + 8 mg IV; highly probably diagnosis if unequivocally positive • For ocular or cranial MG: exclude intracranial lesions by CT or MRI

T or F?

A

T

54
Q

is most commonly used for diagnostic testing because of the rapid onset (30s) and short duration (5 min) of its effect

A

Edrophonium

55
Q

• This test evaluates weakness (eg. Ptosis, partial or complete ophthalmoplegia, and forced hand grip) in an involved group of muscles before and after IV administration

A

Edrophonium

56
Q

How to do the edrophonium test?

A
  • 1 mg (0.1 ml) of edrophonium is given intravenously; if this dose is tolerated and no definite improvement in strength occurs after 45s, another 3 to 6 mg is injected. If there is no response after another 45 s, an additional 3 to 5 mg may be given over approximately 1 min.
  • A total dose of 10 mg is rarely necessary.
  • Most patients who respond do so after 3 to 5 mg have been administered.
57
Q

If the patient is symptomatic, what is the manafement?

A
  1. Cholinesterase inhibitors: Block hydrolysis of Ach at cholinergic synapses, which allows Ach to accumulate and have a prolonged effect.
  2. Potassium channel antagonist: 3,4-Diaminopyridine (3,4 DAP) prolongs the presynaptic nerve action potential thus facilitating calcium influx. 3,4 DAP is very effective in the treatment of LEMS and some forms of CMSs, but it is an investigation medication available only on a compassionate use basis in the United States.
58
Q

immunomodulatory management in NMJDs?

A
  1. Corticosteroids
  2. Immunosuppressant agents: Allow for steroid sparing or additive effects in disease modification. Examples: azathioprine, mycophenolate mofetil, cyclosporine, cyclophosphamide, and methotrexate.
  3. Rescue therapies: Intravenous immunoglobulin and plasma exchange are used for severe or life-threatening symptoms for rapid (but transient) improvement.
59
Q

prophylactic management for NMJDs?

A
  1. Low calorie, low salt diet when managed with corticosteroids.
  2. Agents for bone health maintenance when managed with corticosteroids.
  3. Antibiotic pneumocystis pneumonia prophylaxis when multiple immunomodulatory agents are implemented.
60
Q

MG treatment options?

A
  • Long acting anticholinesterase
  • Pyridostigmine bromide
  • Neostigmine bromide
  • Immunosuppressives
  • Systemic Steroids
  • Azathioprine
  • Cyclosporine A
  • Methotrexate
  • Cyclphosphamide
  • Surgical thymectomy
  • Plasmpharesis
  • IV Immunoglobulin

CMED 311 (47 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions